|Code saturation versus meaning saturation: how many interviews are enough?|
MM Hennink, BN Kaiser, VC Marconi
Qualitative health research 27 (4), 591-608, 2017
|The major genetic determinants of HIV-1 control affect HLA class I peptide presentation|
International HIV Controllers Study
Science 330 (6010), 1551-1557, 2010
|Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study|
N Crum-Cianflone, KH Hullsiek, V Marconi, A Weintrob, A Ganesan, ...
AIDS (London, England) 23 (1), 41, 2009
|Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study|
JF Okulicz, VC Marconi, ML Landrum, S Wegner, A Weintrob, A Ganesan, ...
The Journal of infectious diseases 200 (11), 1714-1723, 2009
|Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa|
VC Marconi, H Sunpath, Z Lu, M Gordon, K Koranteng-Apeagyei, ...
Clinical infectious diseases 46 (10), 1589-1597, 2008
|Anal cancers among HIV-infected persons: HAART is not slowing rising incidence|
NF Crum-Cianflone, KH Hullsiek, VC Marconi, A Ganesan, A Weintrob, ...
AIDS (London, England) 24 (4), 535, 2010
|Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility|
W He, S Neil, H Kulkarni, E Wright, BK Agan, VC Marconi, MJ Dolan, ...
Cell host & microbe 4 (1), 52-62, 2008
|CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms|
MJ Dolan, H Kulkarni, JF Camargo, W He, A Smith, JM Anaya, T Miura, ...
Nature immunology 8 (12), 1324-1336, 2007
|HIV treatment adherence, drug resistance, virologic failure: evolving concepts|
J B Nachega, V C Marconi, G U van Zyl, E M Gardner, W Preiser, ...
Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2011
|Increasing rates of obesity among HIV-infected persons during the HIV epidemic|
N Crum-Cianflone, MP Roediger, L Eberly, M Headd, V Marconi, ...
Plos one 5 (4), e10106, 2010
|Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study|
J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ...
The Lancet infectious diseases 16 (5), 565-575, 2016
|Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression|
TD Burt, BK Agan, VC Marconi, W He, H Kulkarni, JE Mold, M Cavrois, ...
Proceedings of the National Academy of Sciences 105 (25), 8718-8723, 2008
|Baricitinib plus remdesivir for hospitalized adults with Covid-19|
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
|The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States|
CS Kraft, AL Hewlett, S Koepsell, AM Winkler, CJ Kratochvil, LA Larson, ...
Clinical infectious diseases 61 (4), 496-502, 2015
|CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals|
SK Ahuja, H Kulkarni, G Catano, BK Agan, JF Camargo, W He, ...
Nature medicine 14 (4), 413-420, 2008
|Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007|
JE Tate, ML Bunning, L Lott, X Lu, J Su, D Metzgar, L Brosch, CA Panozzo, ...
The Journal of infectious diseases 199 (10), 1419-1426, 2009
|Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care|
PG Farnham, C Gopalappa, SL Sansom, AB Hutchinson, JT Brooks, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 64 (2), 183-189, 2013
|Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States|
AM Liddell, RT Davey Jr, AK Mehta, JB Varkey, CS Kraft, GK Tseggay, ...
Annals of internal medicine 163 (2), 81-90, 2015
|In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine|
R Paredes, M Sagar, VC Marconi, R Hoh, JN Martin, NT Parkin, ...
Journal of virology 83 (4), 2038-2043, 2009
|High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen|
H Sunpath, B Wu, M Gordon, J Hampton, B Johnson, MYS Moosa, ...
Aids 26 (13), 1679-1684, 2012